Search research articles
Contact Us
Filters
Showing results (71-80 of 1,111) with videos related to
Page
of 112
Sort By:
The American Journal of Medicine
|
August 12, 2019
The Reply
Julien Bezin, Nicholas Moore, Philippe Gabriel Steg, et al.
European Heart Journal
|
January 31, 2013
Benefit of revascularization for stable ischaemic heart disease: the jury is still out
Amir-Ali Fassa, William Wijns, Philippe Kolh, et al.
Cardiovascular Drugs and Therapy
|
December 24, 2021
Correction to: The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Journal of the American College of Cardiology
|
August 23, 2014
Lack of negative interaction between use of β-blockers and statins on cardiovascular outcomes among patients with or at risk for atherothrombosis
Jérémie Abtan, Yedid Elbez, Deepak L Bhatt, et al.
Circulation
|
February 21, 2007
Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database
Carine Milcent, Brigitte Dormont, Isabelle Durand-Zaleski, et al.
Journal of the American College of Cardiology
|
February 21, 2004
News from the European Society of Cardiology congress in Vienna, August 30 to September 3, 2003
Otto A Smiseth, P Gabriel Steg, Karin Sipido, et al.
European Heart Journal
|
January 5, 2016
The year in cardiology 2015: coronary intervention
Philippe Gabriel Steg, Patrick W Serruys, Mohammad Abdelghani, et al.
Cardiovascular Drugs and Therapy
|
November 9, 2021
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Cardiovascular Drugs and Therapy
|
January 10, 2022
Response to the Letter on "The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus"
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Archives of Cardiovascular Diseases
|
October 16, 2012
Does lay media ranking of hospitals reflect lower mortality in treating acute myocardial infarction?
Karine Chevreul, Amélie Prigent, Isabelle Durand-Zaleski, et al.
Page
of 112
Search research articles
Search
Showing results (71-80 of 1,111) with videos related to
Sort By:
Page
of 112
The American Journal of Medicine
|
August 12, 2019
The Reply
Julien Bezin, Nicholas Moore, Philippe Gabriel Steg, et al.
European Heart Journal
|
January 31, 2013
Benefit of revascularization for stable ischaemic heart disease: the jury is still out
Amir-Ali Fassa, William Wijns, Philippe Kolh, et al.
Cardiovascular Drugs and Therapy
|
December 24, 2021
Correction to: The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Journal of the American College of Cardiology
|
August 23, 2014
Lack of negative interaction between use of β-blockers and statins on cardiovascular outcomes among patients with or at risk for atherothrombosis
Jérémie Abtan, Yedid Elbez, Deepak L Bhatt, et al.
Circulation
|
February 21, 2007
Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database
Carine Milcent, Brigitte Dormont, Isabelle Durand-Zaleski, et al.
Journal of the American College of Cardiology
|
February 21, 2004
News from the European Society of Cardiology congress in Vienna, August 30 to September 3, 2003
Otto A Smiseth, P Gabriel Steg, Karin Sipido, et al.
European Heart Journal
|
January 5, 2016
The year in cardiology 2015: coronary intervention
Philippe Gabriel Steg, Patrick W Serruys, Mohammad Abdelghani, et al.
Cardiovascular Drugs and Therapy
|
November 9, 2021
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Cardiovascular Drugs and Therapy
|
January 10, 2022
Response to the Letter on "The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus"
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Archives of Cardiovascular Diseases
|
October 16, 2012
Does lay media ranking of hospitals reflect lower mortality in treating acute myocardial infarction?
Karine Chevreul, Amélie Prigent, Isabelle Durand-Zaleski, et al.
Page
of 112